- Home
- GSHD vs PGEN Comparison
GSHD vs PGEN Comparison
Compare GSHD & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GSHD | PGEN |
|---|---|---|
| Founded | 2003 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.2B |
| IPO Year | 2018 | 2013 |
Fundamental Metrics
Financial Performance| Metric | GSHD | PGEN |
|---|---|---|
| Price | $59.91 | $6.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $72.50 | $8.33 |
| AVG Volume (30 Days) | 266.0K | ★ 4.1M |
| Earning Date | 04-22-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.04 | 0.03 |
| Revenue | ★ $365,304,000.00 | $230,981,000.00 |
| Revenue This Year | $16.40 | $1,115.92 |
| Revenue Next Year | $18.53 | $81.04 |
| P/E Ratio | ★ $54.98 | $228.33 |
| Revenue Growth | ★ 16.15 | N/A |
| 52 Week Low | $33.68 | $2.99 |
| 52 Week High | $84.36 | $7.72 |
Technical Indicators
Market Signals| Indicator | GSHD | PGEN |
|---|---|---|
| Relative Strength Index (RSI) | 39.46 | 52.94 |
| Support Level | $40.71 | $6.60 |
| Resistance Level | $76.20 | $7.30 |
| Average True Range (ATR) | 2.96 | 0.25 |
| MACD | -1.89 | -0.08 |
| Stochastic Oscillator | 23.59 | 28.94 |
Price Performance
Historical ComparisonAbout GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions. The company is has a single reportable segment: insurance distribution.
About PGEN Precigen Inc.
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.